A detailed history of Boston Partners transactions in Abbott Laboratories stock. As of the latest transaction made, Boston Partners holds 3,732,864 shares of ABT stock, worth $481 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
3,732,864
Previous 3,790,687 1.53%
Holding current value
$481 Million
Previous $394 Million 8.05%
% of portfolio
0.53%
Previous 0.51%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $5.79 Million - $6.83 Million
-57,823 Reduced 1.53%
3,732,864 $426 Million
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $1.85 Million - $2.06 Million
-18,361 Reduced 0.48%
3,790,687 $394 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $3.98 Million - $4.4 Million
36,378 Added 0.96%
3,809,048 $433 Million
Q4 2023

Feb 07, 2024

BUY
$90.19 - $110.4 $338 Million - $413 Million
3,742,912 Added 12577.83%
3,772,670 $415 Million
Q3 2023

Nov 07, 2023

BUY
$95.53 - $114.62 $2.46 Million - $2.95 Million
25,707 Added 634.58%
29,758 $2.88 Million
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $2,418 - $2,694
24 Added 0.6%
4,051 $441,000
Q1 2023

May 09, 2023

SELL
$96.86 - $114.01 $2,130 - $2,508
-22 Reduced 0.54%
4,027 $407,000
Q4 2022

Feb 07, 2023

SELL
$95.06 - $111.52 $1.24 Million - $1.46 Million
-13,085 Reduced 76.37%
4,049 $444,000
Q3 2022

Nov 09, 2022

SELL
$96.76 - $112.03 $304,213 - $352,222
-3,144 Reduced 15.5%
17,134 $1.66 Million
Q2 2022

Aug 10, 2022

SELL
$102.07 - $123.37 $181,378 - $219,228
-1,777 Reduced 8.06%
20,278 $2.2 Million
Q1 2022

May 10, 2022

SELL
$114.02 - $139.04 $992,772 - $1.21 Million
-8,707 Reduced 28.3%
22,055 $2.61 Million
Q4 2021

Feb 04, 2022

SELL
$115.53 - $141.46 $828,234 - $1.01 Million
-7,169 Reduced 18.9%
30,762 $4.33 Million
Q3 2021

Nov 05, 2021

SELL
$116.66 - $129.06 $1.67 Million - $1.85 Million
-14,331 Reduced 27.42%
37,931 $4.48 Million
Q2 2021

Aug 12, 2021

SELL
$105.79 - $124.53 $4.77 Million - $5.61 Million
-45,076 Reduced 46.31%
52,262 $6.06 Million
Q1 2021

May 10, 2021

SELL
$108.84 - $128.23 $1.52 Million - $1.8 Million
-14,010 Reduced 12.58%
97,338 $11.7 Million
Q4 2020

Feb 04, 2021

SELL
$105.0 - $114.42 $109 Million - $119 Million
-1,036,806 Reduced 90.3%
111,348 $12.2 Million
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $6.47 Million - $7.86 Million
-70,587 Reduced 5.79%
1,148,154 $125 Million
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $48.1 Million - $61.6 Million
-628,705 Reduced 34.03%
1,218,741 $111 Million
Q1 2020

May 13, 2020

BUY
$62.82 - $91.86 $6.77 Million - $9.9 Million
107,762 Added 6.19%
1,847,446 $146 Million
Q4 2019

Feb 06, 2020

BUY
$78.51 - $87.4 $137 Million - $152 Million
1,739,684 New
1,739,684 $151 Million
Q4 2019

Feb 05, 2020

SELL
$78.51 - $87.4 $150 Million - $167 Million
-1,911,913 Closed
0 $0
Q3 2019

Nov 20, 2019

SELL
$81.84 - $88.74 $8.47 Million - $9.19 Million
-103,511 Reduced 5.14%
1,911,913 $160 Million
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $5,810 - $6,300
71 Added 0.0%
2,015,424 $169 Million
Q2 2019

Aug 09, 2019

SELL
$72.88 - $85.0 $8.15 Million - $9.5 Million
-111,798 Reduced 5.26%
2,015,353 $169 Million
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $141 Million - $170 Million
2,127,151 New
2,127,151 $170 Million
Q1 2019

May 03, 2019

SELL
$66.22 - $80.06 $152 Million - $184 Million
-2,295,996 Closed
0 $0
Q4 2018

Feb 07, 2019

SELL
$65.56 - $74.27 $19.1 Million - $21.7 Million
-291,628 Reduced 11.27%
2,295,996 $166 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $2.77 Million - $3.34 Million
45,473 Added 1.79%
2,587,624 $190 Million
Q2 2018

Aug 03, 2018

BUY
$57.57 - $63.54 $12.3 Million - $13.6 Million
213,732 Added 9.18%
2,542,151 $155 Million
Q1 2018

May 04, 2018

BUY
$56.27 - $63.62 $282,362 - $319,245
5,018 Added 0.22%
2,328,419 $140 Million
Q4 2017

Feb 01, 2018

SELL
$53.68 - $57.47 $402 Million - $431 Million
-7,494,862 Reduced 76.34%
2,323,401 $133 Million
Q3 2017

Nov 02, 2017

BUY
$48.06 - $53.64 $472 Million - $527 Million
9,818,263
9,818,263 $524 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.